Agila Specialties Pharma Corporation, Canada, which is part of the injectable drug division of Strides Arcolab, a publicly-held generic drug manufacturer, has formed a joint venture with Jamp Pharma, a Canadian generic drug company, to introduce a variety of quality injectable generic drugs in Canada.
This sales and marketing joint venture will operate under the name ‘Agila-Jamp Canada Inc’ in which Agila will hold a 70 per cent stake and the remaining by Jamp Pharma. The JV will be headquartered in Boucherville, Québec. Agila-Jamp will launch around 40 products in the next two years.
Many of these products have already been approved by Health Canada and will be immediately launched through local hospitals and pharmacists. The existing sales force at Jamp Pharma will be responsible to introduce the entire Agila-Jamp product portfolio.